Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Kura Oncology's total debt was $9.83M at Sep 30, 2026. For fiscal 2025 it was $9.71M, up 2.0% from the year before. The highest annual figure on record is $9.71M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.71M | +2.0% |
| FY2024 | Dec 31, 2024 | $9.52M | +2.0% |
| FY2023 | Dec 31, 2023 | $9.33M | +1.9% |
| FY2022 | Dec 31, 2022 | $9.16M | +26.3% |
| FY2020 | Dec 31, 2020 | $7.25M | -3.3% |
| FY2019 | Dec 31, 2019 | $7.50M | 0.0% |
| FY2018 | Dec 31, 2018 | $7.50M | +5.7% |
| FY2017 | Dec 31, 2017 | $7.10M | -3.1% |
| FY2016 | Dec 31, 2016 | $7.32M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.83M | +1.7% |
| Q2 FY2026 | Jun 30, 2026 | $9.79M | +1.8% |
| Q1 FY2026 | Mar 31, 2026 | $9.75M | +1.9% |
| Q4 FY2025 | Dec 31, 2025 | $9.71M | +2.0% |
| Q3 FY2025 | Sep 30, 2025 | $9.67M | +2.1% |
| Q2 FY2025 | Jun 30, 2025 | $9.62M | +2.1% |
| Q1 FY2025 | Mar 31, 2025 | $9.57M | +2.1% |
| Q4 FY2024 | Dec 31, 2024 | $9.52M | +2.0% |
| Q3 FY2024 | Sep 30, 2024 | $9.47M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | $9.42M | +1.9% |
| Q1 FY2024 | Mar 31, 2024 | $9.38M | +1.9% |
| Q4 FY2023 | Dec 31, 2023 | $9.33M | +1.9% |
| Q3 FY2023 | Sep 30, 2023 | $9.29M | +42.9% |
| Q2 FY2023 | Jun 30, 2023 | $9.24M | +27.5% |
| Q1 FY2023 | Mar 31, 2023 | $9.20M | +22.7% |
| Q4 FY2022 | Dec 31, 2022 | $9.16M | +22.1% |
| Q1 FY2021 | Mar 31, 2021 | $6.50M | -13.3% |
| Q4 FY2020 | Dec 31, 2020 | $7.25M | -3.3% |
| Q3 FY2020 | Sep 30, 2020 | $7.50M | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $7.50M | 0.0% |
| Q1 FY2020 | Mar 31, 2020 | $7.50M | 0.0% |
| Q4 FY2019 | Dec 31, 2019 | $7.50M | 0.0% |
| Q3 FY2019 | Sep 30, 2019 | $7.50M | +19.7% |
| Q2 FY2019 | Jun 30, 2019 | $7.50M | +7.7% |
| Q1 FY2019 | Mar 31, 2019 | $7.50M | +4.8% |
| Q4 FY2018 | Dec 31, 2018 | $7.50M | +5.7% |
| Q3 FY2018 | Sep 30, 2018 | $6.27M | -11.0% |
| Q2 FY2018 | Jun 30, 2018 | $6.96M | -5.3% |
| Q1 FY2018 | Mar 31, 2018 | $7.16M | -2.5% |
| Q4 FY2017 | Dec 31, 2017 | $7.10M | -3.1% |
| Q3 FY2017 | Sep 30, 2017 | $7.04M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.36M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.32M | – |
See a number that looks wrong?